EARLY STAGE PARKINSON'S DISEASE

Clinical trials for EARLY STAGE PARKINSON'S DISEASE explained in plain language.

Never miss a new study

Get alerted when new EARLY STAGE PARKINSON'S DISEASE trials appear

Sign up with your email to follow new studies for EARLY STAGE PARKINSON'S DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 2

New drug MTX325 enters first human tests for Parkinson's

Disease control Recruiting now

This early-stage study tests a new drug called MTX325 in healthy volunteers and people with mild to moderate Parkinson's disease. The main goals are to check safety, how the body processes the drug, and whether it reaches the brain. If successful, MTX325 might one day slow the pr…

Matched conditions: EARLY STAGE PARKINSON'S DISEASE

Phase: PHASE1 • Sponsor: Mission Therapeutics • Aim: Disease control

Last updated Jul 31, 2026 00:00 UTC

EARLY STAGE PARKINSON'S DISEASE

Get alerted when new EARLY STAGE PARKINSON'S DISEASE trials appear

New drug MTX325 enters first human tests for Parkinson's